A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Wing, Lindon M.H., Reid, Christopher M., Ryan, Philip, Beilin, Lawrence J., Brown, Mark A., Jennings, Garry L.R., Johnston, Colin I., McNeil, John J. +4 more·2003·New England Journal of Medicine

DOI 10.1056/nejmoa021716

Cited by (1,000)

Items 501–600 of 1,000

A Pair of “ACEs”
Elliot V. Hersh, Mark Steven Wolff, Paul A. Moore, Katherine N. Theken, Henry Daniell · 2021 · Journal of Dental Research
The role of the AT1 receptor in the cardiovascular continuum
Sven Waßmann · 2004 · European Heart Journal Supplements
Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years
Alan H. Gradman · 2009 · Drugs & Aging
Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan
Emílio Antônio Francischetti, Bruno Miguel Jorge Celoria, Aloísio Francischetti, Virginia A. Genelhu · 2008 · Expert Review of Cardiovascular Therapy
Hypertension treatment and implications of recent cardiovascular outcome trials
Michael A. Weber · 2006 · Journal of Hypertension
Blood pressure lowering and stroke
Monica Saini, Ashfaq M Shuaib · 2010 · Expert Review of Neurotherapeutics
Management of cardiovascular risk with RAS inhibitor/CCB combination therapy
Björn Dahlöf · 2008 · Journal of Human Hypertension
Long-Term Effects of Antihypertensive Drugs on the Risk of New-Onset Diabetes in Elderly Taiwanese Hypertensives
Yi‐Sheng Liou, Tsochiang Ma, Liyun Tien, Ching-Wen Chien, Pesus Chou, Gwo‐Ping Jong · 2008 · International Heart Journal
Review: Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?
Penelope Talelli, Richard Greenwood · 2008 · Therapeutic Advances in Cardiovascular Disease
Epidemiology of Cardiovascular Disease
Christopher Michael Reid, Alice J. Owen · 2016 · Springer eBooks
Rationale for Combination Therapy in the Management of Hypertension
Marvin Moser · 2003 · Journal of Clinical Hypertension
Continued importance of diuretics and β-adrenergic blockers in the management of hypertension
Marvin Moser, John Francis Setaro · 2004 · Medical Clinics of North America
Meta-analyses: first-rank evidence or second-hand information?
Alberto Zanchetti · 2011 · Nature Reviews Cardiology
Pathophysiologic therapeutic targets in hypertension: a cardiological point of view
Gabriele Fragasso, Francesco Maranta, Claudia Montanaro, Anna Salerno, Camilla Torlasco, Alberto Margonato · 2012 · Expert Opinion on Therapeutic Targets
Thiazide diuretics for hypertension: Prescribing practices and predictors of use in 194,761 elderly patients with hypertension
Karen Tu, Norm R.C. Campbell, Zhong‐Liang Chen, Finlay Aleck McAlister · 2006 · The American Journal of Geriatric Pharmacotherapy
Stroke in Chronic Kidney Disease
Raymond R. Townsend · 2008 · Clinical Journal of the American Society of Nephrology
Most Important Outcomes Research Papers on Hypertension
Ruijun Chen, Kumar Dharmarajan, Vivek Kulkarni, Natdanai Punnanithinont, Aakriti Gupta, Behnood Bikdeli, Purav S. Mody, Isuru Ranasinghe · 2013 · Circulation Cardiovascular Quality and Outcomes
Healthy lifestyle status, antihypertensive treatment and the risk of heart failure among Finnish men and women
Yujie Wang, Jaakko Tuomilehto, Pekka Jousilahti, Riitta Antikaínen, Markku Mähönen, Peter Todd Katzmarzyk, Gang Hu · 2013 · Journal of Hypertension
Antihypertensive treatment and prevention of stroke and dementia
J WANG, Jan A. Staessen, W. H. Birkenhäger · 2003 · Seminars in Cerebrovascular Diseases and Stroke
Arterial Hypertension and Stroke Prevention: An Update
Natan M. Bornstein, Giorgio Silvestrelli, Valeria Caso, Lucilla Parnetti · 2006 · Clinical and Experimental Hypertension
Zofenopril Plus Hydrochlorothiazide Fixed Combination in the Treatment of Hypertension and Associated Clinical Conditions
Stefano Omboni, Ettore Malacco, Gianfranco Parati · 2009 · Cardiovascular Therapeutics
L’hypertension artérielle du sujet âgé
Pierre‐François Plouin, Patrick Rossignol, Guillaume Bobrie · 2006 · Bulletin de l Académie Nationale de Médecine
Transcriptome of hypertension-induced left ventricular hypertrophy and its regression by antihypertensive therapies
Julio Gallego‐Delgado, Susan B. Connolly, Alberto Lázaro, Denise M. Sadlier, Niamh E. Kieran, DECLAN D. SUGRUE, Peter Doran, Hugh R. Brady, Julio Osende, Jesús Egido · 2009 · Hypertension Research
Effect of Losartan and Amlodipine on Left Ventricular Diastolic Function in Patients With Mild-to-Moderate Hypertension (J-ELAN) Rationale and Design
The J-ELAN Investigators · 2005 · Circulation Journal
Comentarios a la nueva guía de hipertensión arterial de la Sociedad Española de Hipertensión
A. Morales Salinas · 2005 · Hipertensión
Association between blood pressure and disability-free survival among community-dwelling elderly patients receiving antihypertensive treatment
Osamu Iritani, Yumi Koizumi, Yuko Hamazaki, Hiroshi Yano, Takuro Morita, Taroh Himeno, Tazuo Okuno, Masashi Okuro, Kunimitsu Iwai, Shigeto Morimoto · 2014 · Hypertension Research
Back to thiazide-diuretics for hypertension: reflections after a decade of irrational prescribing
Atle Fretheim · 2003 · BMC Family Practice
A review of chemical therapies for treating diabetic hypertension
Pantelis A. Sarafidis, Maria Eleni Alexandrou, Luis Miguel Ruilope · 2017 · Expert Opinion on Pharmacotherapy
Why Are We Still Using Hydrochlorothiazide?
Clive Rosendorff · 2011 · Journal of Clinical Hypertension
Stroke prevention in women: Challenges and opportunities
Cheryl Bushnell · 2008 · Current Atherosclerosis Reports
Association between higher rates of cardioprotective drug use and survival in patients on dialysis
Yuexin Tang, John M. Brooks, James B. Wetmore, Theresa I. Shireman · 2014 · Research in Social and Administrative Pharmacy
Prediction of Cardiovascular Events in Subjects in the Second Australian National Blood Pressure Study
Mark Raymond Nelson, Philip Ryan, Andrew Maxwell Tonkin, Emmae N. Ramsay, Kristyn J. Willson, Lindon M H Wing, Christopher Michael Reid · 2010 · Hypertension
Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study
Schaefer Saul, Daniel A. Duprez, W Zhong, G Grandits, Jay N. Cohn · 2012 · Journal of Human Hypertension
Ten-year legacy effects of baseline blood pressure ‘treatment naivety’ in the Second Australian National Blood Pressure study
Mark Raymond Nelson, E. Chowdhury, Jenny A Doust, Christopher Michael Reid, Lindon M H Wing · 2015 · Journal of Hypertension
Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle
Dino Premilovac, Emily Attrill, Stephen Rattigan, Stephen Michael Richards, Jeong‐a Kim, Michelle A. Keske · 2018 · Cardiovascular Research
Hypertension in the Elderly
Toshio Ogihara, Hiromi Rakugi · 2005 · Drugs & Aging
Use of Angiotensin‐Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy to Reduce Cardiovascular Events in High‐Risk Patients: Part 1
William J. Bommer · 2008 · Preventive Cardiology
Role of angiotensin II receptor blockers in atherosclerotic plaque stability
Francesco Cipollone, Maria Luigia Fazia, Andrea Mezzetti · 2006 · Expert Opinion on Pharmacotherapy
Pharmacotherapy Review: Angiotensin‐Converting Enzyme Inhibitors
Domenic A. Sica · 2005 · Journal of Clinical Hypertension
ACE inhibitors and target organ protection
Robert D. Toto, Steven Rinner, C. Venkata S. Ram · 2004 · Postgraduate Medicine
The role of angiotensin antagonism in stroke prevention in patients with hypertension: focus on losartan
Carlos Maria Ferrario · 2004 · Current Medical Research and Opinion
Optimising management of hypertension in primary care: The Valsartan Intensified Primary Care Reduction of Blood Pressure (Viper-Bp) Study
Simon Stewart, Melinda Jane Carrington, Carla H. Swemmer, Nicol Kurstjens, Garry Jennings · 2011 · International Journal of Cardiology
Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
Sadaf Ghajarieh Sepanlou, Farshad Farzadfar, Elham Jafari, Goodarz Danaei · 2012 · PubMed
Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart Study
Nisha Bansal, Ronit Katz, Jonathan Himmelfarb, Maryam Afkarian, Bryan R. Kestenbaum, Ian H. de Boer, Bessie Ann Young · 2016 · Nephrology Dialysis Transplantation
Assessment of cardiovascular risk and choice of antihypertensive therapy
William B. Kannel, Ramachandran Srini Vasan · 2004 · Current Hypertension Reports
Not Just Chlorthalidone: Evidence-Based, Single Tablet, Diuretic Alternatives to Hydrochlorothiazide for Hypertension
George C. Roush, Michael E. Ernst, John B. Kostis, Ramandeep Kaur, Domenic A. Sica · 2015 · Current Hypertension Reports
Relationship of aortic excess pressure obtained using pressure-only reservoir pressure analysis to directly measured aortic flow in humans
Michael Michail, Om Prakash Narayan, Kim H. Parker, James D. Cameron · 2018 · Physiological Measurement
Effects of Valsartan on Fibrinolysis in Hypertensive Patients With Metabolic Syndrome
Masaaki Miyata, Yoshiyuki Ikeda, Shuji Nakamura, Takeshi Sasaki, Satoshi Abe, Shinichi Minagoe, Hiroyuki Torii, Souki Lee, Shigeki Tateishi, Koichi Kihara et al. · 2012 · Circulation Journal
Progress Report on the Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Status at February 2004
Keiko Hosohata, Shin Saito, Kei Asayama, Takayoshi Ohkubo, Masahiro Kikuya, Hirohito Metoki, Taku Obara, Tetsuo Kato, Junichiro Hashimoto, Kazuhito Totsune et al. · 2007 · Clinical and Experimental Hypertension
Effects of sex and hypertension subtype on haemodynamics and left ventricular diastolic function in older patients with stage 1 hypertension
Naoki Fujimoto, Yoshiyuki Okada, Shigeki Shibata, Stuart A. Best, Tiffany B. Bivens, Benjamin D. Levine, Qi Fu · 2013 · Journal of Hypertension
Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters
Rémi Goupil, Dominique Dupuis, Stéphan Troyanov, François Madore, Mohsen Agharazii · 2016 · Journal of Hypertension
Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives
Lindon M H Wing, E. Chowdhury, Christopher Michael Reid, Lawrence Joseph Beilin, Mark Ashley Brown · 2018 · Blood Pressure Monitoring
Candesartan and hydrochlorothiazide in isolated systolic hypertension
Lindon M H Wing, Leonard Arnolda, Jane M. Upton, Danielle Molloy · 2003 · Blood Pressure
Hypertension and Stroke
John David Spence, Robert R Hammond · 2016 · Springer eBooks
Do we need to target ‘prediabetic’ hypertensive patients?
J. Segura, Carlos Campo, Luis Miguel Ruilope, José Luis Rodicio · 2005 · Journal of Hypertension
Cautionary tales in the clinical interpretation of therapeutic trial reports
Ian A Scott, P. B. Greenberg · 2005 · Internal Medicine Journal
Public funding of large‐scale clinical trials in Australia
John J. McNeil, Mark Raymond Nelson, Andrew Maxwell Tonkin · 2003 · The Medical Journal of Australia
Legacy in Cardiovascular Risk Factors Control: From Theory to Future Therapeutic Strategies?
Lucie Pothen, Jean‐Luc Balligand · 2021 · Antioxidants
Valsartan Decreases Platelet Activity and Arterial Thrombotic Events in Elderly Patients with Hypertension
Fang Wu, Hongyan Wang, Fan Cai, Ling-Jie Wang, Fengru Zhang, Xiaonan Chen, Qian Yang, Menghui Jiang, Xuefeng Wang, Weifeng Shen · 2015 · Chinese Medical Journal
Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study
for the OlmeSartan Calcium Antagonists Randomized (OSCAR) Study Group, Kunihiko Matsui, Shokei Kim‐Mitsuyama, Hisao Ogawa, Tomio Jinnouchi, Hideaki Jinnouchi, Kikuo Arakawa · 2014 · Hypertension Research
Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study
Gianfranco Parati, Alessia Giglio, Laura Maria Lonati, Maurizio Destro, Alessandra Rossi Ricci, Francesca Cagnoni, Claudio Pini, Achille Venco, Andrea Maria Maresca, M Monza et al. · 2010 · Clinical Therapeutics
Irbesartan improves arterial compliance more than lisinopril
Khalid Ali · 2009 · Vascular Health and Risk Management
Persistence and adherence to antihypertensive treatment in relation to initial prescription
Valentina Trimarco, Giovanni DE SIMONE, Raffaele Izzo, Nicola DE LUCA, Renata Giudice, Marina Marino, Silvia Damiano, Francesco Rozza, Bruno Trimarco, Gianfranco Di Renzo · 2012 · Journal of Hypertension
Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study
Martin C. S. Wong, R. K. C. Lau, Jianfa Jiang, Sian Meryl Griffiths · 2011 · Journal of Clinical Pharmacy and Therapeutics
Diuretics in the Treatment of Hypertension
Michael E. Ernst, Samuel J. Mann · 2011 · Seminars in Nephrology
Microalbuminuria and diabetic cardiovascular disease
Richard J. MacIsaac, Mark Emmanuel Cooper · 2003 · Current Atherosclerosis Reports
Effects of Treatment with Zofenopril in Men and Women with Acute Myocardial Infarction: Gender Analysis of the SMILE Program
Flavia Franconi, Stefano Omboni, Ettore Ambrosioni, Giorgio Reggiardo, Ilaria Campesi, Claudio Borghi · 2014 · PLoS ONE
Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results
Keiko NAKAYAMA, Yoichi Kuwabara, Masao Daimon, Satoshi Shindo, Miwa Fujita, Hiroya Narumi, Hiroshi MIZUMA, Issei Komuro · 2008 · Hypertension Research
Inhibitors of the renin-angiotensin-aldosterone system
Lionel Henry Opie, Marc Alan Pfeffer · 2013 · Elsevier eBooks
Hypertension: A Review and Rationale of Treatment
J. Brian Copley, Reinaldo Rosario · 2005 · Disease-a-Month
???Beyond blood pressure??? means multiple risk factor intervention, not pleiotropic antihypertensive drugs
Jan A. Staessen, Lutgarde Thijs, Yan Li, Tatiana Kuznetsova, Tom Richart, Ji‐Guang Wang, Willem Birkenh ger · 2007 · Current Opinion in Cardiology
Selection bias introduced by the informed consent process
Nina Hannover Bjarnason, Jens Peter Kampmann · 2003 · The Lancet
ASHP Therapeutic Position Statement on the Treatment of Hypertension
Alan J. Zillich, Stuart T. Haines · 2006 · American Journal of Health-System Pharmacy
Primary and secondary prevention of stroke by antihypertensive drug treatment
Ji‐Guang Wang, Yan Li · 2004 · Expert Review of Neurotherapeutics
Should chlorthalidone be the diuretic of choice for antihypertensive therapy?
Sandra J. Taler · 2008 · Current Hypertension Reports
Prevalence, prescribing and barriers to effective management of hypertension in older populations: a narrative review
Tariq M. Alhawassi, Ines Krass, Lisa Pont · 2015 · Journal of Pharmaceutical Policy and Practice
Antihypertensive therapy and cerebrovascular protection
Massimo Volpe, Giuliano Tocci · 2006 · Current Opinion in Nephrology & Hypertension
Effects on 24-hour blood pressure variability of ace-inhibition and calcium channel blockade as monotherapy or in combination
Gianfranco Parati, Paolo Castiglioni, Stefano Omboni, Andrea Faini · 2018 · Scientific Reports
Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial
Steven Clay Rogers, Yi‐An Ko, Arshed Ali Quyyumi, Ihab M. Hajjar · 2022 · Hypertension
Trends of blood pressure, raised blood pressure, hypertension and its control among Italian adults: CUORE Project cross-sectional health examination surveys 1998/2008/2018
Chiara Donfrancesco, Anna Di Lonardo, Cinzia Lo Noce, Brigitta Buttari, Elisabetta Profumo, Francesca Vespasiano, Serena Vannucchi, Ferruccio Galletti, Graziano Onder, Michele Massimo Gulizia et al. · 2022 · BMJ Open
Schlaganfall und Hypertonie
Joachim Schrader · 2009 · Der Internist
Physical activity, alcohol and tobacco use and associated cardiovascular morbidity and mortality in the Second Australian National Blood Pressure study cohort
Mark Raymond Nelson, A. N. Alkhateeb, Philip Ryan, Kristyn J. Willson, Jan Gartlan, Christopher Michael Reid · 2009 · Age and Ageing
Optimal treatment of hypertension in the elderly: A Korean perspective
Kwang‐Il Kim, Young‐Seok Cho, Dong‐Ju Choi, Cheol‐Ho Kim · 2008 · Geriatrics and gerontology international/Geriatrics & gerontology international
Gender difference in the response to valsartan/amlodipine single-pill combination in essential hypertension (China Status II): An observational study
Huan Wang, Hui Chen · 2016 · Journal of the Renin-Angiotensin-Aldosterone System
Use of Calcium Channel Antagonists for the Treatment of Hypertension in the Elderly
Hans‐Michael Steffen · 2004 · Drugs & Aging
Redefining efficacy of antihypertensive therapies beyond blood pressure reduction - the role of angiotensin II antagonists
Paul R. Conlin · 2005 · International Journal of Clinical Practice
Treating Diastolic Heart Failure With AGE Crosslink Breakers: Thinking Outside the Heart Failure Box
Margaret M. Redfield · 2005 · Journal of Cardiac Failure
Metabolic effects of antihypertensive treatment
Ele Ferrannini, M. Kozàkovà · 2003 · Journal of Hypertension
What kind of randomized trials do patients and clinicians need?
Merrick Zwarenstein, Shaun Treweek, PhD · 2009 · Annals of Internal Medicine
Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial
Eun Joo Cho, Moo Hyun Kim, Young‐Hak Kim, Kiyuk Chang, Dong‐Ju Choi, Woong Chol Kang, Jinho Shin, Seong Hwan Kim, Namho Lee, Jang‐Won Son et al. · 2023 · Journal of Clinical Hypertension
Renin-Angiotensin-Aldosterone System Modulators in Adults with Hypertension: A Network Meta-Analysis of Randomized Controlled Trials
Xiaoyan Yi, Shumin Yang, Jun Yang, Xiangjun Chen, Aipin Zhang, Qinglian Zeng, Wenjin Luo, Qifu Li, Jinbo Hu · 2024 · Drugs
JCS/JCC/JACR/JATS 2024 Guideline on Cardiovascular Practice With Consideration for Diversity, Equity, and Inclusion
Yayoi Tetsuou Tsukada, Chizuko Aoki‐Kamiya, Atsushi Mizuno, Atsuko Nakayama, Tomomi Ide, Rie Aoyama, Junko Honye, Katsuyuki Hoshina, Toshimi Ikegame, Koki Inoue et al. · 2025 · Circulation Journal
Sex as a biological variable: a contemporary perspective
Fatima Farrukh, Richard Clinton Becker · 2025 · American Heart Journal
Trajectories of kidney function and risk of mortality
Anna C. van der Burgh, Sanaz Sedaghat, M. Arfan Ikram, Ewout Jasper Hoorn, Layal Chaker · 2023 · International Journal of Epidemiology
Cardiovascular Events in Subgroups of Patients During Primary Treatment of Hypertension With Candesartan or Losartan
David Russell, Jan Stålhammar, Johan Bodegård, Pål Hasvold, Marcus Thuresson, Sverre Erik Kjeldsen · 2010 · Journal of Clinical Hypertension
Disease Management for Hypertension
Deborah A Turnbull, Justin Beilby, Tahereh Ziaian, Farooq Qureshi, Mark Raymond Nelson, Anne Tonkin, John E. Marley · 2006 · Disease Management & Health Outcomes
Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients
Jason P. Swindle, Paul Buzinec, Şerban R. Iorga, Krishnan Ramaswamy, Sumeet S. Panjabi · 2011 · Current Medical Research and Opinion
Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
F.W. Kirsch, Christian Becker, Christoph Kurz, Lars Schwettmann, Anja Schramm · 2020 · BMC Health Services Research
Perindopril: do randomised, controlled trials support an ACE inhibitor class effect? A meta-analysis of clinical trials.
Jacques Rene Snyman, François Wessels · 2009 · Europe PMC (PubMed Central)
Geschlechterunterschiede in der kardiovaskulären Pharmakotherapie
Vera Regitz‐Zagrosek, Carola Schubert · 2008 · Der Internist